Search research articles
Contact Us
Filters
Showing results (111-120 of 160) with videos related to
Page
of 16
Sort By:
Cancer Cell
|
February 16, 2005
Lack of PTEN sequesters CHK1 and initiates genetic instability
Janusz Puc, Megan Keniry, Hong Shen Li, et al.
Cancer
|
November 15, 2018
A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer
Rana R McKay, Lillian Werner, Susanna J Jacobus, et al.
Cancers
|
August 27, 2021
Circulating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer
Edoardo Francini, Fang-Shu Ou, Justin Rhoades, et al.
Cancer Research
|
March 5, 2020
<i>ATM</i> Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer
Shahrzad Rafiei, Kenyon Fitzpatrick, David Liu, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA
Yaping Liu, Sarah C Reed, Christopher Lo, et al.
JCO Precision Oncology
|
February 19, 2021
Enrichment of FGFR3-TACC3 Fusions in Patients With Bladder Cancer Who Are Young, Asian, or Have Never Smoked
Amin H Nassar, Kevin Lundgren, Mark Pomerantz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2020
Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib
Abhishek Tripathi, Jeffrey G Supko, Kathryn P Gray, et al.
Nature Communications
|
March 30, 2024
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA
Yaping Liu, Sarah C Reed, Christopher Lo, et al.
Biomedical Optics Express
|
January 20, 2017
Endoscopic sensing of alveolar pH
D Choudhury, M G Tanner, S McAughtrie, et al.
Nature Communications
|
January 17, 2023
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 160) with videos related to
Sort By:
Page
of 16
Cancer Cell
|
February 16, 2005
Lack of PTEN sequesters CHK1 and initiates genetic instability
Janusz Puc, Megan Keniry, Hong Shen Li, et al.
Cancer
|
November 15, 2018
A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer
Rana R McKay, Lillian Werner, Susanna J Jacobus, et al.
Cancers
|
August 27, 2021
Circulating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer
Edoardo Francini, Fang-Shu Ou, Justin Rhoades, et al.
Cancer Research
|
March 5, 2020
<i>ATM</i> Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer
Shahrzad Rafiei, Kenyon Fitzpatrick, David Liu, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA
Yaping Liu, Sarah C Reed, Christopher Lo, et al.
JCO Precision Oncology
|
February 19, 2021
Enrichment of FGFR3-TACC3 Fusions in Patients With Bladder Cancer Who Are Young, Asian, or Have Never Smoked
Amin H Nassar, Kevin Lundgren, Mark Pomerantz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2020
Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib
Abhishek Tripathi, Jeffrey G Supko, Kathryn P Gray, et al.
Nature Communications
|
March 30, 2024
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA
Yaping Liu, Sarah C Reed, Christopher Lo, et al.
Biomedical Optics Express
|
January 20, 2017
Endoscopic sensing of alveolar pH
D Choudhury, M G Tanner, S McAughtrie, et al.
Nature Communications
|
January 17, 2023
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, et al.
Page
of 16